Your browser doesn't support javascript.
loading
The power of empirical data; lessons from the clinical registry initiatives in Scandinavian cancer care.
Nilbert, Mef; Thomsen, Linda Aagaard; Winther Jensen, Jens; Møller, Henrik; Borre, Michael; Widenlou Nordmark, Arvid; Lambe, Mats; Brändström, Helena; Kørner, Hartwig; Møller, Bjørn; Ursin, Giske.
Affiliation
  • Nilbert M; Department of Oncology, Lund University, Lund, Sweden.
  • Thomsen LA; The Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Winther Jensen J; Clinical Research Department, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark.
  • Møller H; The Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Borre M; The Danish Clinical Quality Program and Clinical Registries, Aarhus, Denmark.
  • Widenlou Nordmark A; The Danish Clinical Quality Program and Clinical Registries, Aarhus, Denmark.
  • Lambe M; The Association of Danish Multidisciplinary Cancer Groups, Aarhus, Denmark.
  • Brändström H; The Federation of Regional Cancer Centers, Stockholm, Sweden.
  • Kørner H; The Federation of Regional Cancer Centers, Stockholm, Sweden.
  • Møller B; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Ursin G; The Federation of Regional Cancer Centers, Stockholm, Sweden.
Acta Oncol ; 59(11): 1343-1356, 2020 Nov.
Article in En | MEDLINE | ID: mdl-32981417
BACKGROUND: In Scandinavia, there is a strong tradition for research and quality monitoring based on registry data. In Denmark, Norway and Sweden, 63 clinical registries collect data on disease characteristics, treatment and outcome of various cancer diagnoses and groups based on process-related and outcome-related variables. AIM: We describe the cancer-related clinical registries, compare organizational structures and quality indicators and provide examples of how these registries have been used to monitor clinical performance, develop prediction models, assess outcome and provide quality benchmarks. Further, we define unmet needs such as inclusion of patient-reported outcome variables, harmonization of variables and barriers for data sharing. RESULTS AND CONCLUSIONS: The clinical registry framework provides an empirical basis for evidence-based development of high-quality and equitable cancer care. The registries can be used to follow implementation of new treatment principles and monitor patterns of care across geographical areas and patient groups. At the same time, the lessons learnt suggest that further developments and coordination are needed to utilize the full potential of the registry initiative in cancer care.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Neoplasms Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2020 Type: Article Affiliation country: Sweden

Full text: 1 Database: MEDLINE Main subject: Neoplasms Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2020 Type: Article Affiliation country: Sweden